New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Clinical trial NCT01174537 · WITHDRAWN

Trial details

NCT number: NCT01174537
Sponsor: Hadassah Medical Organization
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Sarcoma Neuroblastoma

Start date: 2011-07-01
Primary completion: 2011-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.